Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes

Viral Immunology

Volumn 13, Issue 2, 2000, Pages 169-178

  Tuteja, Renu ^a,c   Li, Tian Cheng ^b   Takeda, Naokazu ^b   Jameel, Shahid ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS E VACCINE; HEPATITIS VACCINE; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TARGETING; HEPATITIS E; HEPATITIS E VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; NONHUMAN;

ANIMALIA; DNA VIRUSES; HEPATITIS E VIRUS; MURINAE; RNA VIRUSES; UNIDENTIFIED BACULOVIRUS;

EID: 0033918819     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2000.13.169     Document Type: Article

References (35)

1. Arora, N.K., S.K. Nanda, S. Gulati, I.H. Ansari, M.K. Chawla, S.D. Gupta, and S.K. Panda. 1996. Acute viral hepatitis types E, A and B singly and in combination in acute liver failure in children in North India. J. Med. Virol. 48:215-221.
2. Aye, T.T., T. Uchida, X.-Z. Ma, F. Iida, T. Shikata, H. Zhuang, and K.M. Win. 1993. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res. 20:3512.
3. Barouch, D.H., S. Santra, T.D. Steenbeke, X.X. Zheng, H.C. Perry, M.-E. Davis, D.C. Freed, A. Craiu, T.B. Strom, J.B. Shiver, and N.L. Letvin. 1998. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration, J. Immunol. 161:1875-1882.
4. Bi, S.-L., M.A. Purdy, K.A. McCaustland, H.S. Margolis, and D.W. Bradley. 1993. The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China. Virus Res. 28:233-247.
5. Borgne, S.L., M. Mancini, R.L. Grand, M. Schleaf, D. Dormant, P. Tiollais, Y. Riviere, and M.-L. Michel. 1998. In vivo induction of specific cytotoxic T lymphocytes in mice and Rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology. 240:304-315.
6. Chow, Y-H., B.-L. Chiang, Y.-L. Lee, W.-K. Chi, W-C. Lin, Y.-T. Chen, and M.-T. Tao. 1998. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by co-delivery of various cytokine genes. J. Immunol. 160:1320-1329.
7. Chow, Y.-H., W.-L. Huang, W.-K. Chi, Y.-D. Chu, and M.-H Tao. 1997. Improvement of hepatitis B virus DNA vaccines by plasmids co-expressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:169-178.
8. Davis, H.L., Mancini, M.-L. Michel, and R.G. Whalen. 1996. DNA-mediated immunization to hepatitis B surface antigen: Longevity of primary response and effect of boost. Vaccine. 14:910-915.
9. Davis, H.L., M.J. McCluskie, J.L. Gerin, and R.H. Purcell. 1996. DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA. 93:7213-7218.
10. Disis, M.L., H. Bernard, P.M. Shiota, S.L. Hand, J.R. Gralow, E.S. Huseby, S. Gillis, and M.A. Cheever. 1996. Granulocyte-macrophage colony stimulating factor: An effective adjuvant for protein and peptide based vaccine. Blood. 88:202-210.
11. Donnelly, J.J., J.B. Ulmer, J.W. Shiver, and M.A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617-648.
12. Geissler, M., A. Gesien, K. Tokushige, and J.R. Wands. 1997. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158:1231-1237.
13. He, J., S.L. Hoffman, and C.G. Haves. 1997. DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine. 15:357-362.
14. Huang, C.-C., D. Nguyen, J. Fernandez, K.Y. Yun, K.E. Fry, D.W. Bradley, A.W. Tam, and G.R. Reyes. 1992. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology. 191:550-558.
15. Jameel, S., M. Zafrullah, M.H. Ozdener, and S.K. Panda. 1996. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J. Virol. 70:207-216.
16. Kaur, M., K.C. Hvams, M.A. Purdy, K. Krawczynski, W.M. Ching, K.E. Fry, G.R. Reves. D.W. Bradley, and M. Carl. 1992. Human linear B-cell epitopes encoded by the hepatitis E virus includes determinants in the RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. USA. 89:3855-3858.
17. Khudyakov, Y.E., M.O. Favorov, D.L. Jue, T.K. Hine, and H.A. Fields. 1994. Immunodominant antigenic regions in a structural protein of the Hepatitis E virus. Virology. 198:390-393.
18. Kuroo, M.S., M.R. Teli, S. Skidmore, M.A. Sofi, and M.I. Khuroo. 1981. Incidence and severity of viral hepatitis in pregnancy. Am. J. Med. 70:252-255.
19. Krawczynski, K. 1993. Hepatitis E. Hepatology 17:932-941.
20. Li, T.-C., Y. Yamakawa, K. Suzuki, M. Tatsumi, M.A.A. Razak, M.T. Uchida, N. Takeda, and T. Miyamura. 1997. Expression and self assembly of empty virus-like particles of hepatitis E virus. J. Virol. 71:7207-7213.
21. McDonnell, W.M. and F.K. Askari. 1996. DNA vaccines. N. Engl. J. Med. 334:42-45.
22. Meng, J., J. Pillot, X. Dai, H.A. Fields, and Y.E. Khudyakov. 1998. Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources. Virology. 249:316-324.
23. Nunberg, J.H., M.V. Doyle, S.M. York, and C.J. York. 1989. Interleukin-2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc. Natl. Acad. Sci. USA. 86:4240-4243.
24. Okada, E., S. Sasaki, N. Ishii, I. Aoki, T. Yasuda, K. Nishioka, J. Fukushima, J.-I. Miyazaki, B. Wahren, and K. Okuda. 1997. Intranasal immunization of a DNA vaccine with IL-12 and granulocyte-macrophage colony stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:3638-3647.
25. Oppenheim, J.J., C.O. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617-648.
26. Panda, S.K., and S. Jameel. 1997. Hepatitis E virus: From epidemiology to molecular biology. Viral. Hep. Rev. 3:227-251.
27. Panda, S.K., S.K. Nanda, H. Durgapal, H. Ozdner, M. Zafrullah, I.H. Ansari, R.S. Mehra, and S. Jameel. 1997. Diagnostic and protective immune status of hepatitis E virus structural antigens, pp 321-326, in: Viral hepatitis and liver disease ed. M. Rizzetto, R.H. Purcell, J.L. Gerin, and G. Verme, eds. Edizioni Minerva Medica. Turin.
28. Tarn, A.W., M.M. Smith, M.E. Guerra, C.-C. Huang, D.W. Bradley, K.E. Frey, and Reyes, G.R. 1991. Hepatitis E virus (HEV): Molecular cloning and sequencing of the full length viral genomes. Virology. 185:120-131.
29. Tsarev, S.A., S.U. Emerson, G.R. Reves, T.S. Tsareva, L.J. Legters, A. Malik, M. Iqbal, and R.H. Purcell. 1992. Characterization of a prototype strain of hepatitis E virus. Proc. Natl. Acad. Sci. USA. 89:559-563.
30. Tsarev, S.A., T.S. Tsareva, S.U. Emerson, S. Govindrajan, M. Shapiro, J.L. Gerin, and R.H. Purcell. 1994. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc. Natl. Acad. Sci. USA. 91:10198-10202.
31. Tuteja, R. 1999. DNA vaccines: A ray of hope. Crit. Rev. Biochem. Mol. Biol. 34:1-24.
32. Ulmer, J.B., J.J. Donnelly, and M.A. Liu. 1996. Toward the development of DNA vaccine. Curr. Opin. Biotechnol. 7:653-658.
33. Wang, Y., R. Ling, J.C. Erker, H. Zhang, H. Li, S. Desai, I.K. Mushahwar, T.J. Harrison. 1999. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J. Gen. Virol. 80:169-177.
34. Weinberg, A., and T.C. Merigen. 1988. Recombinant interleukin-2 as an adjuvant for vaccine-induced protection: Immunization of guinea pigs with herpes simplex virus subunit vaccines. J. Immunol. 140:294-299.
35. Xiang, Z., and H.C.J. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by co-inoculation with plasmid expressing cytokines. Immunity. 2:129-135.